120-W 2-µm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up.
Identifieur interne : 000771 ( Main/Merge ); précédent : 000770; suivant : 000772120-W 2-µm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up.
Auteurs : Christopher Netsch [Allemagne] ; Laura Pohlmann ; Thomas R W. Herrmann ; Andreas J. Gross ; Thorsten BachSource :
- BJU international [ 1464-410X ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Humains, Hyperplasie de la prostate (), Hyperplasie de la prostate (anatomopathologie), Hyperplasie de la prostate (diagnostic), Lasers à solide (effets indésirables), Lasers à solide (usage thérapeutique), Mâle, Prostate (anatomopathologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Thulium.
- MESH :
- anatomopathologie : Hyperplasie de la prostate, Prostate.
- diagnostic : Hyperplasie de la prostate.
- effets indésirables : Lasers à solide.
- usage thérapeutique : Lasers à solide.
- Adulte d'âge moyen, Humains, Hyperplasie de la prostate, Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus, Thulium.
English descriptors
- KwdEn :
- MESH :
- chemical : Thulium.
- adverse effects : Lasers, Solid-State.
- diagnosis : Prostatic Hyperplasia.
- pathology : Prostate, Prostatic Hyperplasia.
- surgery : Prostatic Hyperplasia.
- therapeutic use : Lasers, Solid-State.
- Aged, Aged, 80 and over, Humans, Male, Middle Aged.
Abstract
Study Type - Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Thulium VapoEnucleation of the prostate (ThuVEP) has been introduced as a minimally invasive treatment modality of benign prostate obstruction (BPO). This study reports the largest series of patients with symptomatic BPO undergoing ThuVEP. Efficacy of this procedure was confirmed by prostate volume and PSA measurements at 12-month follow up, which have not been reported after ThuVEP so far.
DOI: 10.1111/j.1464-410X.2011.10767.x
PubMed: 22085294
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000408
- to stream PubMed, to step Curation: 000408
- to stream PubMed, to step Checkpoint: 000408
- to stream Ncbi, to step Merge: 000516
- to stream Ncbi, to step Curation: 000516
- to stream Ncbi, to step Checkpoint: 000516
Links to Exploration step
pubmed:22085294Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">120-W 2-µm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up.</title><author><name sortKey="Netsch, Christopher" sort="Netsch, Christopher" uniqKey="Netsch C" first="Christopher" last="Netsch">Christopher Netsch</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany. c.netsch@asklepios.com</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Urology, Asklepios Hospital Barmbek, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Pohlmann, Laura" sort="Pohlmann, Laura" uniqKey="Pohlmann L" first="Laura" last="Pohlmann">Laura Pohlmann</name></author><author><name sortKey="Herrmann, Thomas R W" sort="Herrmann, Thomas R W" uniqKey="Herrmann T" first="Thomas R W" last="Herrmann">Thomas R W. Herrmann</name></author><author><name sortKey="Gross, Andreas J" sort="Gross, Andreas J" uniqKey="Gross A" first="Andreas J" last="Gross">Andreas J. Gross</name></author><author><name sortKey="Bach, Thorsten" sort="Bach, Thorsten" uniqKey="Bach T" first="Thorsten" last="Bach">Thorsten Bach</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="doi">10.1111/j.1464-410X.2011.10767.x</idno><idno type="RBID">pubmed:22085294</idno><idno type="pmid">22085294</idno><idno type="wicri:Area/PubMed/Corpus">000408</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000408</idno><idno type="wicri:Area/PubMed/Curation">000408</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000408</idno><idno type="wicri:Area/PubMed/Checkpoint">000408</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000408</idno><idno type="wicri:Area/Ncbi/Merge">000516</idno><idno type="wicri:Area/Ncbi/Curation">000516</idno><idno type="wicri:Area/Ncbi/Checkpoint">000516</idno><idno type="wicri:Area/Main/Merge">000771</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">120-W 2-µm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up.</title><author><name sortKey="Netsch, Christopher" sort="Netsch, Christopher" uniqKey="Netsch C" first="Christopher" last="Netsch">Christopher Netsch</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany. c.netsch@asklepios.com</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Urology, Asklepios Hospital Barmbek, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Pohlmann, Laura" sort="Pohlmann, Laura" uniqKey="Pohlmann L" first="Laura" last="Pohlmann">Laura Pohlmann</name></author><author><name sortKey="Herrmann, Thomas R W" sort="Herrmann, Thomas R W" uniqKey="Herrmann T" first="Thomas R W" last="Herrmann">Thomas R W. Herrmann</name></author><author><name sortKey="Gross, Andreas J" sort="Gross, Andreas J" uniqKey="Gross A" first="Andreas J" last="Gross">Andreas J. Gross</name></author><author><name sortKey="Bach, Thorsten" sort="Bach, Thorsten" uniqKey="Bach T" first="Thorsten" last="Bach">Thorsten Bach</name></author></analytic><series><title level="j">BJU international</title><idno type="eISSN">1464-410X</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Humans</term><term>Lasers, Solid-State (adverse effects)</term><term>Lasers, Solid-State (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Prostate (pathology)</term><term>Prostatic Hyperplasia (diagnosis)</term><term>Prostatic Hyperplasia (pathology)</term><term>Prostatic Hyperplasia (surgery)</term><term>Thulium</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Humains</term><term>Hyperplasie de la prostate ()</term><term>Hyperplasie de la prostate (anatomopathologie)</term><term>Hyperplasie de la prostate (diagnostic)</term><term>Lasers à solide (effets indésirables)</term><term>Lasers à solide (usage thérapeutique)</term><term>Mâle</term><term>Prostate (anatomopathologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Thulium</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lasers, Solid-State</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Hyperplasie de la prostate</term><term>Prostate</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hyperplasie de la prostate</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lasers à solide</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Prostate</term><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Lasers, Solid-State</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Lasers à solide</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Humains</term><term>Hyperplasie de la prostate</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Thulium</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Study Type - Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Thulium VapoEnucleation of the prostate (ThuVEP) has been introduced as a minimally invasive treatment modality of benign prostate obstruction (BPO). This study reports the largest series of patients with symptomatic BPO undergoing ThuVEP. Efficacy of this procedure was confirmed by prostate volume and PSA measurements at 12-month follow up, which have not been reported after ThuVEP so far.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000771 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000771 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:22085294
|texte= 120-W 2-µm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:22085294" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |